MoonLake Immunotherapeutics 宣布拟进行1.5亿美元A类普通股及预融资权证公开发行

美股速递
Jun 23

生物技术公司MoonLake Immunotherapeutics披露了一项新的融资计划。该公司宣布,拟进行一项总额高达1.5亿美元的混合证券公开发行。

此次发行将包含其A类普通股以及与之挂钩的预融资权证。公司表示,计划将此次发行所募集的净资金主要用于推进其核心临床管线的发展,包括为相关研发活动提供资金,并补充营运资本及用于其他一般公司用途。

本次发行的具体条款,包括证券数量、发行价格等,将根据市场情况及其他因素最终确定。承销商将被授予一项期权,可在发行定价后30天内额外购买最多15%的拟发行证券。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10